Needham & Co. upgrades ISIS Pharmaceuticals (NASDAQ: ISIS) from Hold to Buy with a $22 price target.

This article: 125 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE